Search

Your search keyword '"Oskoui M"' showing total 315 results

Search Constraints

Start Over You searched for: Author "Oskoui M" Remove constraint Author: "Oskoui M"
315 results on '"Oskoui M"'

Search Results

1. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

2. P76 The Canadian neuromuscular disease registry: a national spinal muscular atrophy registry for real world evidence

8. P.114 SUNFISH parts 1 and 2: 3-year efficacy and safety of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)

12. List of Contributors

16. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

18. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders

19. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders

22. SMA - TREATMENT

23. REGISTRIES AND CARE OF NMD

25. Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era

26. Plasma Phosphorylated Neurofilament Heavy Chain Levels Over Time in Participants With Infantile-and Later-onset SMA: Data from the SHINE Study

27. The Canadian Neuromuscular Disease Registry 2010–2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry

29. SMA - CLINICAL

30. SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES

31. REGISTRIES, CARE, QUALITY OF LIFE, MANAGEMENT OF NMD

33. Effects of McGill Stabilization Exercise on pain and disability, range of motion and dynamic balance indices in patients with chronic nonspecific low back pain

34. Neurofilament as a potential biomarker for spinal muscular atrophy

35. Phosphorylated neurofilament heavy chain (PNF-H) and motor function achievement in nusinersen-treated individuals with spinal muscular atrophy (SMA)

36. P.270Association between plasma phosphorylated neurofilament heavy chain and efficacy endpoints in the nusinersen NURTURE study

39. SMA THERAPIES II AND BIOMARKERS

40. NEW GENES, FUNCTIONS AND BIOMARKERS

45. Procedural and Physical Interventions for Vaccine Injections: Systematic Review of Randomized Controlled Trials and Quasi-Randomized Controlled Trials

46. P.074 Risk factors for perinatal arterial ischemic stroke (PAIS): A machine learning approach

47. C.2 SUNFISH parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)

Catalog

Books, media, physical & digital resources